Global Anti-inflammatory Biologics Market Research Report 2025(Status and Outlook)

Report Overview

The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.

This report provides a deep insight into the global Anti-inflammatory Biologics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-inflammatory Biologics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-inflammatory Biologics market in any manner.

Global Anti-inflammatory Biologics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer

Inc

Novartis

Roche

Sun Pharmaceutical Industries Ltd

Sanofi

GlaxoSmithKline

Market Segmentation (by Type)

Synthetic Type

Biological Type

Market Segmentation (by Application)

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Anti-inflammatory Biologics Market

Overview of the regional outlook of the Anti-inflammatory Biologics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-inflammatory Biologics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anti-inflammatory Biologics
1.2 Key Market Segments
1.2.1 Anti-inflammatory Biologics Segment by Type
1.2.2 Anti-inflammatory Biologics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anti-inflammatory Biologics Market Overview
2.1 Global Market Overview
2.1.1 Global Anti-inflammatory Biologics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Anti-inflammatory Biologics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anti-inflammatory Biologics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Anti-inflammatory Biologics Product Life Cycle
3.3 Global Anti-inflammatory Biologics Sales by Manufacturers (2020-2025)
3.4 Global Anti-inflammatory Biologics Revenue Market Share by Manufacturers (2020-2025)
3.5 Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Anti-inflammatory Biologics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Anti-inflammatory Biologics Manufacturing Sites, Area Served, Product Type
3.8 Anti-inflammatory Biologics Market Competitive Situation and Trends
3.8.1 Anti-inflammatory Biologics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Anti-inflammatory Biologics Industry Chain Analysis
4.1 Anti-inflammatory Biologics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anti-inflammatory Biologics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Anti-inflammatory Biologics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Anti-inflammatory Biologics Market
5.7 ESG Ratings of Leading Companies
6 Anti-inflammatory Biologics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-inflammatory Biologics Sales Market Share by Type (2020-2025)
6.3 Global Anti-inflammatory Biologics Market Size Market Share by Type (2020-2025)
6.4 Global Anti-inflammatory Biologics Price by Type (2020-2025)
7 Anti-inflammatory Biologics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-inflammatory Biologics Market Sales by Application (2020-2025)
7.3 Global Anti-inflammatory Biologics Market Size (M USD) by Application (2020-2025)
7.4 Global Anti-inflammatory Biologics Sales Growth Rate by Application (2020-2025)
8 Anti-inflammatory Biologics Market Sales by Region
8.1 Global Anti-inflammatory Biologics Sales by Region
8.1.1 Global Anti-inflammatory Biologics Sales by Region
8.1.2 Global Anti-inflammatory Biologics Sales Market Share by Region
8.2 Global Anti-inflammatory Biologics Market Size by Region
8.2.1 Global Anti-inflammatory Biologics Market Size by Region
8.2.2 Global Anti-inflammatory Biologics Market Size Market Share by Region
8.3 North America
8.3.1 North America Anti-inflammatory Biologics Sales by Country
8.3.2 North America Anti-inflammatory Biologics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Anti-inflammatory Biologics Sales by Country
8.4.2 Europe Anti-inflammatory Biologics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Anti-inflammatory Biologics Sales by Region
8.5.2 Asia Pacific Anti-inflammatory Biologics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Anti-inflammatory Biologics Sales by Country
8.6.2 South America Anti-inflammatory Biologics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Anti-inflammatory Biologics Sales by Region
8.7.2 Middle East and Africa Anti-inflammatory Biologics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Anti-inflammatory Biologics Market Production by Region
9.1 Global Production of Anti-inflammatory Biologics by Region(2020-2025)
9.2 Global Anti-inflammatory Biologics Revenue Market Share by Region (2020-2025)
9.3 Global Anti-inflammatory Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Anti-inflammatory Biologics Production
9.4.1 North America Anti-inflammatory Biologics Production Growth Rate (2020-2025)
9.4.2 North America Anti-inflammatory Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Anti-inflammatory Biologics Production
9.5.1 Europe Anti-inflammatory Biologics Production Growth Rate (2020-2025)
9.5.2 Europe Anti-inflammatory Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Anti-inflammatory Biologics Production (2020-2025)
9.6.1 Japan Anti-inflammatory Biologics Production Growth Rate (2020-2025)
9.6.2 Japan Anti-inflammatory Biologics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Anti-inflammatory Biologics Production (2020-2025)
9.7.1 China Anti-inflammatory Biologics Production Growth Rate (2020-2025)
9.7.2 China Anti-inflammatory Biologics Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Anti-inflammatory Biologics Product Overview
10.1.3 AbbVie Anti-inflammatory Biologics Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Anti-inflammatory Biologics Product Overview
10.2.3 Johnson and Johnson Anti-inflammatory Biologics Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Amgen Inc
10.3.1 Amgen Inc Basic Information
10.3.2 Amgen Inc Anti-inflammatory Biologics Product Overview
10.3.3 Amgen Inc Anti-inflammatory Biologics Product Market Performance
10.3.4 Amgen Inc Business Overview
10.3.5 Amgen Inc SWOT Analysis
10.3.6 Amgen Inc Recent Developments
10.4 AstraZeneca PLC
10.4.1 AstraZeneca PLC Basic Information
10.4.2 AstraZeneca PLC Anti-inflammatory Biologics Product Overview
10.4.3 AstraZeneca PLC Anti-inflammatory Biologics Product Market Performance
10.4.4 AstraZeneca PLC Business Overview
10.4.5 AstraZeneca PLC Recent Developments
10.5 Pfizer
10.5.1 Pfizer Basic Information
10.5.2 Pfizer Anti-inflammatory Biologics Product Overview
10.5.3 Pfizer Anti-inflammatory Biologics Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Inc
10.6.1 Inc Basic Information
10.6.2 Inc Anti-inflammatory Biologics Product Overview
10.6.3 Inc Anti-inflammatory Biologics Product Market Performance
10.6.4 Inc Business Overview
10.6.5 Inc Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Anti-inflammatory Biologics Product Overview
10.7.3 Novartis Anti-inflammatory Biologics Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Roche
10.8.1 Roche Basic Information
10.8.2 Roche Anti-inflammatory Biologics Product Overview
10.8.3 Roche Anti-inflammatory Biologics Product Market Performance
10.8.4 Roche Business Overview
10.8.5 Roche Recent Developments
10.9 Sun Pharmaceutical Industries Ltd
10.9.1 Sun Pharmaceutical Industries Ltd Basic Information
10.9.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Overview
10.9.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Market Performance
10.9.4 Sun Pharmaceutical Industries Ltd Business Overview
10.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Anti-inflammatory Biologics Product Overview
10.10.3 Sanofi Anti-inflammatory Biologics Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Basic Information
10.11.2 GlaxoSmithKline Anti-inflammatory Biologics Product Overview
10.11.3 GlaxoSmithKline Anti-inflammatory Biologics Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
11 Anti-inflammatory Biologics Market Forecast by Region
11.1 Global Anti-inflammatory Biologics Market Size Forecast
11.2 Global Anti-inflammatory Biologics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-inflammatory Biologics Market Size Forecast by Country
11.2.3 Asia Pacific Anti-inflammatory Biologics Market Size Forecast by Region
11.2.4 South America Anti-inflammatory Biologics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Anti-inflammatory Biologics by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Anti-inflammatory Biologics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Anti-inflammatory Biologics by Type (2026-2033)
12.1.2 Global Anti-inflammatory Biologics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Anti-inflammatory Biologics by Type (2026-2033)
12.2 Global Anti-inflammatory Biologics Market Forecast by Application (2026-2033)
12.2.1 Global Anti-inflammatory Biologics Sales (K Units) Forecast by Application
12.2.2 Global Anti-inflammatory Biologics Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings